Uncaria tomentosa (Willdenow ex Roemer &
Schultes) De Candolle
1. CLASSIFICATION
Kingdom: Plantae (Plants)
Subkingdom: Tracheobionta (Vascular
plants)
Superdivision: Spermatophyta (Seed plants)
Division: Magnoliophyta (Flowering plants)
Class: Magnoliopsida (Dicotyledons)
Subclass: Asteridae
Order: Rubiales
Family: Rubiaceae (Madder family)
Genus: Uncaria Schreber,
Gen. Pl.: 125. Apr 1789
Species: Uncaria tomentosa
(Willd.) DC
Common Names: “cat’s claw”, “Peruvian
cat’s claw”, “hawk’s claw”. Castilian/Spanish
: Peru “uña de gato”, “uña de gato roja”;
Loreto “garabato colorado”; Ucayali “uña de gato de
altura”, “garabato amarillo”,“bejuco de agua”;
San Martín “garabato”; Others “paraguayo”,
“garabato”, “garabato casha”, “samento”, “toroñ”, “tambor huasca”, “uña
huasca”, “uña de gavilán”, “garra de gavilán”, “saventaro”, “soga de agua”,
“vilcacora”. Asháninka: kug-kukjagui. Portuguese
: “deixa paraguayo”. Others: “unganangui”, “uncucha”,
“tsachik”, “paotati-mösha”, “misho-mentis”, “jipotatsa”,
“torõn”.
2. DESCRIPTION
Habit: Gigantic (very large) perennial
liana (woody vine) that grows climbing around treesor creeping, with hook-like
thorns that grow along the vine and resemble the claws of a cat. These
claw-like projections allow the vine to attach to tree bark and also give the
plant its name. The stem is reddish colored. This species can reach over 30 m
high into the canopy and much more meters in length.
The stem of Uncaria tomentosa (Willd.) DC
can reach several centimeters in diameter and contains a clear watery sap. The
external bark has superficial longitudinal fissures, and the internal bark is
fibrous, with the ground bark the color golden yellow. The sap is watery and
astringent in taste. The terminal branchlets are quadrangular and yellow-green
in color.
Uncaria guianensis, a closely related
species, has thorns that are more curved.
Leaves: Simple, opposite, bright green,
and dimorphic; oblong, oblong-ovate (oval-shaped) or elliptic. The hook-like
thorns grow at the base of the leaves. The underside of the leaf has fine
hairs. The leaf blade is 7.5 cm to 17 cm in length and 5 cm to 12 cm in width.
The leaf margins are entire; apex is acute, or rarely acuminate; base is round
and/or cordate (heart-shaped). The stipules are deltoid, 6 mm to 12 mm long
and 4 mm to 8 mm wide. The spines are woody, occur in pairs, are slightly
curved but straight, and pointy; 8 mm to 10 mm in length and 3 mm to 6 mm in
width.
Flowers: The inflorescences occur in
racemes or globular cymes, are axilary and/or terminal, 7 cm to 18 cm in
length, 1.5 cm to 2.5 cm in diameter. Flowers are bisexual, actinomorphic and
sessile. The calyx is gamosepalous, tubular, 1 mm to 1.5 mm in length and 0.8
mm to 1 mm in diameter. The corolla is gamopetalous, 7 mm to 13 mm in length,
3 mm to 5 mm in diameter, with 5 round lobes; yellow. Stamens are sessil;
5-fused to the throat. The anthers are oblong with prolonged and divergent
bases; 1 mm to 1.2 mm in length and 0.3 mm to 0.4 mm in width. The stigma is
ellipsoid, 0.5 mm in length, with linear 4 mm long styles; inferior ovary.
Uncaria guianensis, a closely related
species, has reddish-orange flowers.
Fruit:The fruits are dry and dehiscent;
elliptic capsules; 5 mm to 8 mm long and 3 mm to 6 mm wide.
3. ORIGIN, DISTRIBUTION AND
ECOLOGY
Origin: Uncaria tomentosa (Willd.)
DC is native to the Amazon basin, particularly to Peru.
Distribution: Uncaria tomentosa
proliferates spontaneously all over the Amazon rainforest, especially in the
upper Amazon region of Peru and neighboring countries, and other tropical
areas of South and Central America, including Peru, Colombia, Ecuador, Guyana,
Trinidad, Venezuela, Suriname, Costa Rica, Guatemala, and Panama. It has also
been reported as far North as Belize, and South into Paraguay. Maranhao,
Brazil, is the most Eastern area where Uncaria tomentosa has been
reported to grow naturally. There are as many as 60 species related to this
plant.
Uncaria tomentosa, which is used
by Indian shamans, can be found on the mountain slopes in the jungle. It is
most frequent in the Montaña in Peru.
In Peru, Uncaria guianensis (Aubl.) J. F.
Gmel., a closely related species, has been reported in Amazonas, Ayacucho,
Cuzco, Huánuco, Loreto, Madre de Dios, San Martín, and Ucayali.
Ecology: Uncaria tomentosa is a
ligneous climbing plant that reaches full maturity after about twenty years of
age. According to father Edmund Szelinga —a Polish Salesian missionary living
70 years in Peru— the best part for medicinal purposes is the bark or root of
young Uncaria tomentosa which is around three years old. According to
other authorities, for use in medicine, the bark is removed from the stems of
Uncaria tomentosa vines that are over 8 years old.
The bark is just as efficient as the roots;
therefore the underground parts of the plant should not be exploited, so that
the plant can regenerate. The de-barked vines may be woven into rattan-like
furniture.
Uncaria tomentosa as well as Uncaria
guianensis are both, collected from the wild and cultivated. The best
growing areas for Uncaria tomentosa are in the organic soils between
250 and 900 meters above sea level. Although both are difficult to cultivate,
in some areas of Peru they are usually planted from cuttings of the vine
rather than from seeds. When collected from the wild, they are cut 1 meter
above the ground in order to leave the root undisturbed. The vine can grow
back and reach maturity again in about four years. It can then be harvested
again.
This plant is typical of primary forest, but is
also found in disturbed forest and rarely in secondary forest.
4. HISTORY
Father Edmund Szeliga —an elderly Polish
missionary living in Peru— cited by Rybiński and Warszewski (2000) on their
book ‘Vilcacora, the Miracle Cancer Cure’ states “…the queen of
all the healing plants of Amazon, vilcacora. Its Latin name is Uncaria
tomentosa (Willd.) DC, while in Spanish it is ‘uña de gato’. It’s the
Incas holy vine, whose use once was restricted to the current ruler and his
closest family only. As early as the 1960s at the Naples University, a
detailed chemical analysis was conducted at my commission, which showed that
this plant has a completely unique composition of alkaloids and glycosides,
which inhibits the growth of many varieties of cancer. The infusion from a few
grams of desiccated vilcacora drunk three times a day in quarter of a liter
doses proves to be an extremely successful remedy even at the advanced stages
of the disease. This amazing plant opens up completely new perspectives for
medicine!...”.
Uncaria tomentosa is still considered a
sacred plant among the Ashaninkas and other indigenous Peruvian Amazonian
tribes such as the Campa Indians. Actually, in the Amazon rainforest, there
exist two closely-related species of Uncaria that are used almost
interchangeably. They are Uncaria tomentosa and Uncaria guianensis
, and both are called by the same common name, ‘cat’s claw’ or ‘uña de gato’.
Sometimes, Uncaria tomentosa is called ‘uña de gato roja’ (red cat’s
claw), and Uncaria guianensis, ‘uña de gato blanca’ (white cat’s claw),
in order to differentiate them from each other. According to the Austrian
investigator Klaus Keplinger (1999), these herbs serve as a means of
"regulating the physical and spiritual worlds" for these tribal groups.
In other parts of Latin America, there exist
several other species of plants with a common name of ‘cat’s claw’; however,
they belong to totally different groups of plants other than the genus
Uncaria and family Rubiaceae. In Mexico, for example, there exist several
‘cat’s claw’ species that have toxic properties.
From the perspective of ethnobotany, the higher
a plant's status among native peoples, the more potent it often proves to be
medicinally. Both, Uncaria tomentosa and Uncaria guianensis,
have been being used by the indigenous peoples of the Amazon rainforest since
ancient times for medical purposes. It has been estimated that these species
of Uncaria have been used medicinally by the Aguaruna, Asháninka,
Cashibo, Conibo, and Shipibo tribes of Peru for at least 2 000 years.
The earliest record of use of Uncaria
tomentosa was related to the Asháninka Indian tribe in Central Peru. They
continue using this plant until today and nowadays they are also the largest
commercial source of Uncaria tomentosa from Peru.
The Asháninka Indians live further and deeper
into the jungle than other tribes. All the other tribes learned from the
Asháninkas about the unusual healing properties of Uncaria tomentosa
long before Spanish colonization. The Asháninkas, just like the Incas did
later, worshipped Uncaria tomentosa as a god, and called it
kug-kukjagui. Uncaria tomentosa was to them the highest deity who
gave rise to all other gods. This is why the Indians carved the images of
their minor gods in the mature, ligneous shoots of Uncaria tomentosa.
And because this is a long climbing plant, the gods, as you may find out when
visiting any museum devoted to the Indians of the forest, have very long
profiles and oval faces (Rybiński and Warszewski, 2000).
Asthma, inflammations of the urinary tract and
recovering from childbirth are some of the conditions they treat with the
decoction of this plant. The Asháninka also use Uncaria tomentosa
as a kidney cleanser, to cure deep wounds, for arthritis, rheumatism, and bone
pain. Control of inflammation and gastric ulcers as well as treatment for
cancer are also some of the uses the Asháninka assign to this plant.
This Peruvian ethnic group, as well as several
other different ones, have also been using Uncaria tomentosa as a
contraceptive. Dr. Fernando Cabieses, M.D., a noted authority on Peruvian
medicinal plants, has reported that the Asháninka boil 5 to 6 kilograms of the
root in water until it is reduced to little more than 1 cup. This decoction is
then taken 1 cup daily during the period of menstruation for three consecutive
months, which supposedly causes sterility for three to four years.
In Piura, a region in the Peruvian coast,
indigenous tribes use Uncaria tomentosa to treat tumors, inflammations,
rheumatism, and gastric ulcers.
Other Peruvian indigenous tribes use Uncaria
tomentosa to treat diabetes, urinary tract cancer in women, hemorrhages,
menstrual irregularity, cirrhosis, fevers, abscesses, gastritis, rheumatism,
inflammations; for internal cleansing and tumors; and to normalize the body.
In Colombia, some Indian tribes use Uncaria
tomentosa to treat gonorrhea and dysentery.
In Suriname, the decoction of Uncaria
tomentosa is used against dysentery, intestinal affections and wounds.
In England, some companies are offering massage
creams with Uncaria tomentosa. They are also marketing toothpaste of
Uncaria tomentosa to prevent and cure periodontosis, soaps based on
Uncaria tomentosa as an anti-mycotic with supposed fungistatic activity,
recommended for excessively sweating skin. A shampoo is also sold, recommended
for patients with allergic reactions, psoriasis, sensitive to detergents and
susceptible to hair loss. A hair conditioner as well as an antiseptic and
antimycotic talc as a preventive for mycosis and eczema are also
commercialized.
Due to its many curative properties, Amerindians
consider Uncaria tomentosa a kind of panacea —a cure for anything—. The
most traditional Ashaninkas always carry a kind of bag or basket woven from
some flexible forest bark. The Indians from the jungle use these bags to carry
Uncaria tomentosa a plant which they never part with, a plant that
accompanies them in whatever they do.
Although its uses by native healers have been
known for over fifty years, it was not until Keplinger began studying the
properties of ‘uña de gato’ in 1974 that it began to receive attention for its
potential medicinal value. A 1999 systematic review paper by Keplinger et al
. described an analysis of 55 works summarizing ethnomedical and
pharmacological uses.
The first scientifically controlled studies on
Uncaria tomentosa were performed in the early 1970s when Klaus Keplinger,
a journalist and self-taught ethnologist from Innsbruck, Austria, organized
the first definitive work on Uncaria tomentosa. Attracted by the
several ethnologic reports that documented the many uses of this tropical
vine, Keplinger worked with this plant for several years. His work eventually
led in the early 1990s to the marketing of several extracts of Uncaria
tomentosa in Austria and Germany as herbal drugs with immunomodulating
properties (Keplinger et al., 1999; Gabriel et al., 1999). He
also filed four U. S. patents describing extraction procedures for a group of
chemicals called oxindole alkaloids, and the immunostimulating actions of
these alkaloids, found in this plant.
Keplinger’s studies on Uncaria tomentosa
and its novel oxindole alkaloids called worldwide attention in the medicinal
properties of this valuable vine of the rainforest. Consequently, several
other independent researchers in Spain, France, Japan, Germany and Peru
confirmed Keplinger’s results. Since mid-1990s, some Peruvian physicians are
investigating the use of the extract of Uncaria tomentosa, complemented
with other herbal drugs, in order to treat AIDS.
Many of the studies published after Keplinger’s
work confirmed the immunostimulating properties of the alkaloids in the bark
and roots. The whole oxindole alkaloid fraction, whole Uncaria tomentosa
bark and/or root bark extracts, and six individually-tested oxindole
alkaloids increased immune function by up to 50% in relatively small amounts.
In 1998, independent Peruvian researchers
demonstrated that a whole extract of Uncaria tomentosa increased immune
function in rats at a dosage of 400 mg/kg. In 1999, independent Canadian
researchers at the University of Ottawa reported that a whole Uncaria
tomentosa extract demonstrated a strong immunostimulant effect.
Since 1999, several patented extracts of
Uncaria tomentosa have been manufactured and marketed in the United States
and other developed countries. Clinical studies funded by private companies
continue to be carried out; these studies show that the immunostimulating
benefits of Uncaria tomentosa claimed by Amazon indigenous tribes have
a scientific support.
In the last years, the presence of Uncaria
tomentosa —the ‘original cat’s claw’ species— has declined in the Peruvian
rainforest by overharvesting due to sustained market demand. This species is
getting harder for wild harvesters to find.
Today, the lower-growing and easier to find
Uncaria guianensis is commonly found in many large lots of Uncaria
tomentosa bulk material being exported out of South America. Although it
is easy to tell which is Uncaria tomentosa and which Uncaria
guianensis if one can see the claws or hooks —the hook shapes are
different; even, the leaves of the Uncaria tomentosa species are also
more hairy than those of Uncaria guianensis— these species are
literally indistinguishable after they have been harvested (unless subjected
to chemical analysis). And during harvest, leaves and hooks are sometimes 30
meters above ground in the canopy and obscured by other vegetation (it is only
the lower vine that is cut off in harvesting, whereas the upper vine is
discarded in the top of the canopy where it is wound around everything). By
the time it arrives to the marketers, there is no way to tell if the inner
bark is Uncaria tomentosaor Uncaria guianensis
Uncaria tomentosa generally grows at
higher elevations than Uncaria guianensis, which grows at river level.
This means that Uncaria guianensis is easier to find, easier to get to,
easier to harvest and easier to transport (because it grows near to the
rivers).
The effect of this substitution on the medical
properties is still unknown, although independent phytochemical analysis
shows, however, that both plants contain most all of the same phytochemicals
(including alkaloids), just in different ratios. Further information is
required.
Market demand for ‘cat's claw’ has increased
dramatically in the past 10 years, and a huge amount of Uncaria tomentosa
has been harvested out of the Peruvian Amazon and exported out of Peru.
Brazilian harvesters have entered the market in the last five and are
exporting as well.
In an age of emerging new viruses with stunning
virulence, natural antiviral and immunomodulating substances such as those
from Uncaria tomentosa could play a significant role in human disease
prevention and treatment. Several institutions in Peru, Austria, Germany,
Great Britain, Italy, Switzerland and the United States, among other countries
are conducting today detailed research in Uncaria tomentosa.
Legend: How the Asháninkas where taught
about Uncaria tomentosa
Taken from the book ‘Vilcacora, the
Miracle Cancer Cure’, by G. Rybiński and R. Warszewski (2000)
—————
Tasurinchi was the first Ashaninka. He was the
Indian Adam. He did not have a wife at that moment, because initially he was
alone in the world, and this is why he had to cook, and wash, and hunt on his
own. Tasurinchi’s life was horrible. He toiled away at tasks without number,
and there was no one to help him. His legs hurt from constant chasing of
animals. His hands hurt from stringing beads for necklaces. His head hurt from
constant thinking about how to cope with all his chores.
One day he met a puma as he was walking, or
actually running, through the forest.
— ‘I have a stomach-ache,’ — he complained.
— ‘Why?’ — the puma was surprised.
— ‘Because the food I had yesterday wasn’t
fresh, I guess. Maybe you know, dear puma, what I should do?’
The puma approached a tree, reached for a thick
liana that was entwined around it, and tore off some bark with its claws.
— ‘Suck it under your tongue’ — the puma advised
Tasurinchi —‘This
will help you.’
— ‘What is it?’ — he asked.
— ‘How come you don’t know? It’s
kug-kukjagui (cat’s claw)’.
Tasurinchi listened to the puma and his stomach
stopped aching after a moment. But what of it, if his head still hurt. ‘I have
handled the stomach somehow. What should I do to get rid of this horrible pain
in my head?’ he wondered and kept on running. He must have covered some
kilometer when he met a capybara that was heading towards the river.
— ‘I have an awful headache,’ —he said to the
rodent, instead of ‘Good morning’. ‘Don’t you know, dear capybara, what could
help me?’
The capybara approached a trunk that was
entwined with some plant, and scraped some rustcoloured powder off the strong
stem with its knife-sharp teeth.
— ‘Dissolve this in water and drink it,’ — said
the animal. — ‘You will forget the headache in a moment.’
— ‘What is it?’ asked Tasurinchi.
— ‘How come you don’t know? It’s
kug-kukjagui (cat’s claw).’
Tasurinchi prepared the decoction just as the
capybara had advised him and drank it with a grimace because it was bitter.
Before he managed to think that he should move on, he realised his head did
not hurt any more. ‘Very good,’ he thought. ‘Excellent! Fantastic! But what of
it, if the wound on my hand I had inflicted on myself when forcing my way
through the thickets still smarts...’. A tapir came along from across the way.
— ‘Hello, tapir!’ — exclaimed Tasurinchi. — ‘My
friend, maybe you could advise me how I should dress this smarting wound?’
The tapir sniffed around for a while with his
long nose, and then approached a tree that was clad with some kind of ivy. The
tapir hit the thick stem a few times with its hoof, tore off a piece of the
bark and passed it to Tasurinchi.
— ‘Make a dressing of this bark,’ — said the
animal. — ‘Surely, this will help you. I always dress my hoof with
kug-kukjagui (cat’s claw) whenever I hurt it. We animals have long known
this tried out and tested way...’
— ‘Is this kug-kukjagui
(cat’s claw) as well?’ — Tasurinchi was surprised.
— ‘Why, don’t you recognize it?’
— ‘Could you tear off another piece for me?’ —
asked Tasurinchi, who suddenly realized that he had probably found the
solution to all his problems. ‘I’m in a hurry and I won’t have time to stop,
and I would very much like to have some of this bark for later...’
—————
5. UTILITY
Parts Used: Bark, root, leaves.
· Bark: The part used medicinally is
the inner bark of the vine from which a boiled decoction is made or extracts
produced. The inner bark of Uncaria tomentosa (Willd.) DC contains up
to 0.5% Pentacyclic Oxindole Alkaloids (POA).
· Roots: Although the traditional
part used as medicinal is the bark, in recent years, extracts of the root have
also been prepared commercially. It has never been, however, proven
scientifically that the root or the root bark contains more alkaloids than the
vine bark. In fact, independent lab analysis over the years shows the vine
bark contains an equal or greater percentage of alkaloids than the root and/or
root bark, although there are contradictory results.
· Leaves: Some companies are
marketing pulverized leaves of Uncaria tomentosa. This powder can be
used in order to prepare an infusion the same way as the bark or root is used.
The leaves contain higher levels of Pentacyclic Oxindole Alkaloids than the
stem bark.
Properties:
Uncaria tomentosa is used as:
analgesic
antibacterial
anticancerous
anticoagulant
antidepressant
antidysenteric
antihypertensive
anti-inflammatory
antileukemic
antimutagenic
antioxidant
antiproliferative
antitumorous
antiulcerous
antiviral
blood cleanser
bowel cleanser
bowel protector
cicatrizant
contraceptive
cytoprotective (cellular protector)
cytostatic
cytotoxic
depurative
detoxifier
diuretic
gastrototonic
general daily tonic
hypocholesterolemic
hypotensive
immunomodulatory
immunostimulant
non-specific immuno-modulating agent in viral
illnesses and cancer
stomach protector
tonic
ulcer preventative
vulnerary
Uncaria tomentosa is used for:
acne
adjunctive therapy for cancer (to reduce
chemotherapy side effects and protect cells)
allergy
arthritis (all kinds)
arthrosis
asthma
bone pains
bowel problems
cancer
cerebral ischemia (possible prevention)
chronic inflammation of all kinds
chronic viral infections
cirrhosis
colitis
Crohn's disease
cyst
depression
diabetes
diarrhea
disease prevention
diverticulitis
dysentery
dysmenorrhea (disturbances of the menstrual
cycle)
environmental poisoning
fevers
gastric ulcers
gastritis
gonorrhea
hemorrhages
herpes zoster
IBS
immune disorders
inflammation of joints
inflammations
intestinal affections
kidney cleanser
menstrual irregularity
muscle pains/strains/injuries
neuralgias
osteoarthritis
prevention of radiation damage
prostatitis
rheumatic disorders
rheumatism
rheumatoid arthritis
skin disorders
stomach
stomach ulcers
stomatitis
tumors
ulcerative colitis
ulcers
urinary tract disorders
viral and bacterial co-infections in AIDS
viral diseases
wounds
Although there exist several proprietary
extracts in the market, many authorities believe that the best way to profit
of Uncaria tomentosa is preparing a natural vine bark decoction. They
recommend to get some good quality vine bark and boil it in water in order to
obtain a concentrated decoction, which is the traditional way the Amazonians
use this amazing plant, with all the natural chemicals that nature provides in
the proper ratio. They argue that the invasive ‘purification’ techniques may
only extract one particular type of chemical, or change the complex ratio of
naturally-occurring chemicals in herbal systems, which ignore the natural
synergy of the plant chemicals.
Immune System
There are a number of parallels between plant
immunological activity and the immune systems of mammals, including adaptive
mechanisms for viral resistance. In order to adapt to environmental
aggressions, plants produce a vast number of natural products that have
antimicrobial and immunomodulating potential.
The human immune system is a highly complex and
extraordinarily sophisticated mechanism involving both innate and adaptive
responses. In the last years, basic research on how natural substances
extracted from plants affect immune response has led to the discovery of
several tropical plants such as Uncaria tomentosa, which has gained
popularity as a natural immunostimulant and immunomodulating agent.
Plants from tropical rainforests represent a
rich source of potential immunomodulating substances. Immunomodulating
activity refers to biological or pharmacological effects of compounds on
humoral or cellular aspects of the immune response.
In a 1998 British narrative review paper,
Syrimis magazine concluded that the broad therapeutic application of
Uncaria tomentosa suggests it is a worthy addition to the list of drugs
used to treat the immune system.
In one study (Flores, 1999), Uncaria tomentosa
showed an increase in phagocytosis. In other in vivo Peruvian study,
Mestanza (1999) found that phagocytosis was increased in rats when an extract
of Uncaria tomentosa was administered at a dose of 400 mg/kg. The
strengthening of phagocytosis in turn heightens the organism’s self-defense.
Independent research performed on whole oxindole
extracts and whole root or vine extracts of Uncaria tomentosa reports
the presence of two types of alkaloids in the extracts. These are the
pentacyclic oxindole alkaloids (POA) and the tetracyclic oxindole alkaloids
(TOA). Both of them showed immune stimulant actions.
Monocytes and granulocytes, under the influence
of these alkaloids, take over the function of macrophages, cells attacking
viruses and bacteria. It was noticed that after patients had taken the
infusion of Uncaria tomentosa for a week, the monocytes’ activity rose
by about 50%. The erythrocytes’ resistance to damage grew as well. This means
in practice that the crisis is over and that the organism is beginning to get
better.
Some commercial companies that market patented
formulas extracted from Uncaria tomentosa argue that this plant
produces ‘good alkaloids’ and ‘bad alkaloids.’ According to studies funded by
them, the ‘good ones’ are the pentacyclic oxindole alkaloids (POA) which
are reported to induce a yet unknown immune regulating factor (Muhammad et
al., 2001) and the ‘bad ones’ are the tetracyclic oxindole alkaloids (TOA).
A 1998 study showed that pentacyclic alkaloids weakly activated human B- and
T-lymphocytes, and that tetracyclic oxindole alkaloids reduced the activity of
pentacyclic oxindoles (Wurm et al., 1998).
Presumably, the bad alkaloids counteract the
immune benefits of the good alkaloids. The presence of as little as 1%
tetracyclic oxindole alkaloids content in an Uncaria tomentosa
formulation would diminish the immunostimulant effect of the formulation by as
much as 30%. However, this hypothesis has not yet been confirmed by
independent laboratories, and there are only two studies reporting that, both
of them funded by or performed by the only company selling a TOA-free
Uncaria tomentosa product.
The company that funded these studies is
marketing standardized extracts of the root of Uncaria tomentosa
containing a minimum of 1.3-percent pentacyclic oxindole alkaloids free of
tetracyclic oxindole alkaloids.
Some scientists have proposed that the supposed
‘bad alkaloids’ are not such. Instead, they think that the overexploitation of
Uncaria tomentosa has led the indigenous peoples of the Amazon who collect
the plant from the wild to turn to Uncaria guianensis, a species that
is easier to find and collect. Indeed, today Uncaria guianensis is a
common ‘contaminant’ in many large lots of Uncaria tomentosa
bulk material exported from South America. Although the phytochemical makeup
of both species is similar, the ratio of oxindole alkaloids could be different.
The immunomodulating activity of Uncaria
tomentosa includes suppression of NF-kappa B (Sandoval et al.,
2000), enhancement of B- and T-lymphocytes, stimulation of phagocytosis
(Wagner, 1985), and enhancement of interleukin-1 and interleukin-6 (Lemarie
et al., 2000).
According to Pero (2000), the whole plant
extract is considered a non-specific immunomodulating agent and may be used
synergistically with antioxidant therapy. According to Dr. Klaus
Keplinger, holder of several patents on Uncaria tomentosa from the
Austrian laboratory Immodal, this plant is exceptionally useful in general
stimulation of the immune system, and in multiplying the defensive strength of
the organism.
Finally, it is important to notice that, with a
few exceptions, the majority of studies have been in vitro or in animal
models, with weak to moderate immunomodulating and antiviral effects. As
Williams (2001) says, “…There is no overwhelming evidence to support the
public perception of this herb as a potent immune stimulant, although it
appears to be a beneficial and safe, non-specific immunomodulating botanical.
Further research, both in the laboratory and clinically, is warranted…”.
Cancer
Traditionally, the indigenous peoples of the
Amazon have been using Uncaria tomentosa to treat cancer. In the upper
Amazon, a decoction of the bark of Uncaria tomentosa is mixed with
resin of Croton lechleri Müll. Arg., an herbal product with recognized
potent cytotoxicity against cancer cells, to treat several kinds of cancer.
Western medicine in Peru and Europe started to use extracts of Uncaria
tomentosa as an adjunctive treatment for cancer in the early 1990s.
Some in vitro anticancerous properties
have been documented for the raw extract of Uncaria tomentosa as well
as oxindole alkaloids and other constituents in the extract. Five of the
oxindole alkaloids have been clinically documented with in vitro
antileukemic properties, and various root and bark extracts have demonstrated
antitumorous and antimutagenic properties.
Uncaria tomentosa has the ability to stop
and reverse very advanced pathology, and, what is also important, its
application does not exclude the continuation of therapy with the use of the
methods of traditional medicine. In the 1980s, Keplinger observed that cancer
patients receiving traditional cancer therapies such as chemotherapy and
radiation reported fewer side effects (such as hair loss, weight loss, nausea,
secondary infections, and skin problems) to the traditional therapies when
they were treated with extracts of Uncaria tomentosa.
Dr. Julie Clements, oncologist from the United
States, affirms (cited by G. Rybiński and R. Warszewski, 2000): “There has
been a substantial decrease in the side-effects of radiation treatment and
chemotherapy with respect to my patients suffering from malignant diseases who
have been treated with Uncaria tomentosa. On the basis of a few years’
clinical practice, I also know that applying Uncaria tomentosa, may be
compared in terms of its effects to remission, i.e. the disappearance of
tumors, including substantially large tumors. With time, I have come to like
Uncaria tomentosa so much that I have had my mother use it.”
Subsequent studies have shown that the extract
of Uncaria tomentosa can aid in DNA cellular repair and prevent cells
from mutating, which might explain why the extract allows cancer patients to
better tolerate chemotherapy and radiation. Besides, these studies have also
reported that the extract of Uncaria tomentosa can help prevent
leukopenia (a common chemotherapy side effect consisting in lossing of white
blood cells) and immune damage caused by many chemotherapy drugs.
According to Peruvian Dr. Victor Incháustegui,
however, plant therapy should not be used during radiotherapy and
chemotherapy. He recommends maintaining a three-day interval between
chemotherapy or radiotherapy and phytotherapy, and vice versa. The results are
particularly favorable if such a time sequence is observed.
In 1993 at the Instituto de Medicina
Tradicional (IMET, Institute of Traditional Medicine) Dr. Teodoro Cerruti
and others separate from Uncaria tomentosa the alkaloids
isopteropodine, pteropodine, isomitraphiline, unkarine, mitraphiline, and
speciophiline. Colonies of leukemia, HL-60 and U-937, were subjected to their
effect.
After the colometric tests with the use of
agar-agar, the slowing-down effect on colonies of leukemia cells of alkalis
separated from Uncaria tomentosa appeared to be clear and measurable.
Various concentrations of alkalis were used in that experiment and their
effect lasted up to the seventh day after the experiment had finished.
Moreover, through colometric and
spectrophotometric analyses, the survival ability of pathological cells and
the number of colonies of HL-60 and U-937 cells were assessed. They obtained
the following results: It was stated that isopteropodine, pteropodine,
isomitraphiline, unkarine and speciophiline alkalis have a strong inhibitory,
i.e. slowing-down, effect on the growth of leukemia cells from the HL-60
and U-937 lines. This appeared to be directly proportional to the dose of
alkalis administered during the experiment.
The most effective alkali here is unkarine F. In
its case the value of IC-50 was achieved, which means that this substance has
reacted to at least 50% of leukemia cells, which, in turn, in clinical
experience means the beginning of the illness’s regress. Unkarine F worked
selectively and was able to differentiate between pathological and healthy
cells. Thanks to this it did not inhibit the growth of healthy cells produced
in the bone marrow. To sum up, it can be said that unkarine F, derived from
Uncaria tomentosa, can be regarded as a strong drug which is effective
against leukemia.
Several studies also at the Instituto de
Medicina Tradicional, Iquitos, Peru, performed on animals, have shown that
Uncaria tomentosa heightens the capacity of the immune system to react to
cancerous cells. The experiments conducted there show the particular
efficiency of Uncaria tomentosa in overcoming breast, prostate, lung
and stomach tumours.
Dr. Cerruti, however, notices that not every
disease that they can cure in the case of rats is, with the use of similar
methods, equally curable in the case of people. Although they have obtained
very interesting results from the research conducted on animals, these results
are not definitive.
In 1998, a scientific Swedish team reported that
the extract of Uncaria tomentosa inhibited the growth of lymphoma and
leukemia cells in vitro.
In 2001, a medical Italian team reported that
some extracts and their chromatographic fractions from the bark of Uncaria
tomentosa directly inhibited the growth in vitro of a human breast
cancer cell line MCF7 by 90%. Their data indicated that, in addition to the
antimutagenic activity, Uncaria tomentosa extracts and fractions exert
a direct antiproliferative activity on MCF7. The bioassay-directed
fractionation from barks and leaves resulted in the isolation of two active
fractions, which displayed an IC50 of 10 mg/ml and 20 mg/ml, respectively and
an antiproliferative effect, with about 90% of inhibition at a concentration
of 100 mg/ml. Moreover, another team reported that it inhibited the binding of
estrogens in human breast cancer cells in vitro.
Dr Richard Geber, author of the best-seller book
‘Vibrational Medicine’, assures that Uncaria tomentosa
decreases the effects of radiation treatment and chemotherapy, which are
inevitable when treating new growth tumors with conventional methods.
In their book, G. Rybiński and R. Warszewski
(2000) cite four studies related to Uncaria tomentosa and cancer. i) In
a group of three patients suffering from colon and ovary cancer, the new
growth tumor disappeared in two cases after 4 and 7 months and became
substantially smaller in one case. ii) In a group of twenty-two patients
suffering from various varieties of new growth tumors, there was remission in
13 cases, i.e. the tumor disappeared, and the other patients lived longer than
5 years. iii) In the most numerous group of seventy-eight patients suffering
from brain cancer, the disappearance of the tumors was observed with respect
to all patients after a year. iv) In other clinical examinations where the
efficiency of Uncaria tomentosa was tested with respect to three women
of 42, 58, and 80 years of age suffering from ovary, uterus, and colon
cancers, an amazing improvement was observed in all cases, including the
disappearance of the tumors. These authors do not mention, however, the
sources of these results.
Finally, in an online article by the Center for
Alternative Medicine Research in Cancer (
www.sph.uth.tmc.edu/utcam/therapies/cat/htm) they concluded that, although the
results of the 43 studies carried out in Uncaria tomentosa reviewed by
them were very positive in terms of cancer regression, they did not provide
substantial information on use in cancer and were not well documented.
Anti-inflammatory
In any kind of lesion, from the shortest cut in
a finger to burnings and chronic affections such as arthritis and Alzheimer,
there is an inflammatory process involved. This process is natural and allows
the lesions to cicatrize.
Traditionally, the Asháninka Indian tribe in
Central Peru uses a decoction of Uncaria tomentosa to treat
inflammations of the urinary tract. They also use it to control inflammation
related to arthritis and rheumatism. In order to treat arthritis, they
sometimes use Uncaria tomentosa in combination with other local herbs
such as chuchuhuasi bark.
In Western countries, Uncaria tomentosais
included in some herbal combination remedies, e.g. with capsaicin in
the arthritis cream, Nikken Anti-Arthritis. Some Essiac tea mixtures now
contain Uncaria tomentosa in addition to the four traditional
ingredients (burdock root, sheep sorrel, turkey rhubarb root and slippery elm
bark).
Other Peruvian Indian tribes also use a water
extract of Uncaria tomentosa in order to treat inflammations such as
gastritis (stomach inflammation), arthritis (joint inflammation) and other
types of inflammatory stomach and bowel disorders.
The anti-inflammatory effect of the water
extract of Uncaria tomentosa can be understood by means of some plant
sterols (beta-sitosterol, stigmasterol, and campesterol) with well-known
anti-inflammatory properties found in this extract. Additionally, in 1991 a
group of novel phytochemicals found in the bark and roots of this plant
(called quinovic acid glycosides) had been documented with anti-inflammatory
properties. Even more, these new phytochemicals have been reported with the
most potent anti-inflammatory effect among all the constituents known in the
plant. Some antioxidant chemicals (catechins and procyanidins) found in the
extract also contribute to the anti-inflammatory properties.
Several subsequent in vivo and in vitro
studies determined that the water extract of Uncaria tomentosa —and,
especially, its glycosides— could inhibit inflammation up to 89%.
In 2000, a study by Sandoval et al.
related to the antioxidant properties of the water extract of Uncaria
tomentosa concluded that the extract is not only an antioxidant but also a
remarkably potent inhibitor of TNF-alpha production. He stated “…
The primary mechanism for cat's claw's anti-inflammatory action appears to be
immunomodulation via suppression of TNF-a synthesis."
TNF-alpha (tumor necrosis factor - alpha) is a
powerful molecule that initiates an inflammatory process. This protein also
allows the recruiting of some specialized cells of the immune system called
macrophages.
TNF represents a model for tumor growth driven
by an inflammatory cytokine. Some researches reported that the primary
mechanism for the anti-inflammatory action of Uncaria tomentosa appears
to be immunomodulation through the suppression of this cytokine.
Water decoction of Uncaria tomentosa have
been traditionally used by Amazonians in order to treat arthritis and
rheumatism. According to Dr Richard Geber, author of the best-seller book ‘
Vibrational Medicine’, this plant has very low toxicity, and thus
may be applied against arthritis even for a longer period of time.
Surprisingly, a patented product comprised of
mostly alkaloids showed only modest benefit to arthritis patients. However, in
2002, scientists from the United States reported that the anti-inflammatory
actions of Uncaria tomentosa are not attributable to immunostimulating
alkaloids. This would explain why the tested commercial formula was scarcely
effective against arthritis.
Other results from animal studies and reports of
human cases show that taking Uncaria tomentosa by mouth has
anti-inflammatory effects for individuals with either osteoarthritis
(degeneration of joint components) or rheumatoid arthritis (an autoimmune
disease in which the body’s immune system attacks cartilage and synovial fluid
in joints).
On the other hand, Uncaria tomentosa
appears to have little or no effect on swelling associated with arthritis, but
study participants who took it reported less pain during exercise. However,
few human studies have been conducted and results have not all been positive.
More research is needed before Uncaria tomentosa may be recommended for
treating arthritis.
Recent researches suggest that the water extract
of Uncaria tomentosa might be helpful to people with Alzheimer's
disease. The reasons for this are not clear. Some authorities think that this
probable property could be related to the anti-inflammatory effect of the
water extract of Uncaria tomentosa; some others believe that it could
be related to the antioxidant effects already confirmed. However, a dilation
of peripheral blood vessels in the brain by alkaloids such as rhynchophylline
has also been proposed as a possibility. Moreover, Uncaria tomentosa
has been demonstrated to retard the deposition of amyloid-beta protein.
Finally, it has been suggested that the extract
of Uncaria tomentosa may protect against gastrointestinal damage
associated with nonsteroidal anti-inflammatory drugs such as ibuprofen.
AIDS
Uncaria tomentosa has been used in Peru
and Europe since the early 1990s as an adjunctive treatment for AIDS, as well
as other diseases that target the immunological system.
Uncaria tomentosa was used to treat AIDS
for the first time in Peru. Peruvian physician Roberto Incháustegui Gonzáles,
who was president of the Comité de SIDA y Enfermedades de Transmisión Sexual
(Committee of AIDS and Venereal Diseases) of the Instituto Peruano de
Seguridad Social (Peruvian Institute of Social Security) at Iquitos, was
the first professional who used experimentally the bark of Uncaria tomentosa
in combination with the rhizome of Dracontium loretense K. Krause to
treat AIDS.
Dr. Incháustegui’s research from 1989 to 1993
came to light in a series of newspaper articles, but it has never been
formally published in a scientific journal. During his research, he
administered an extract of the two mentioned plants to his patients with
amazing results.
Dracontium loretense K. Krause “sacha
jergón” is a well-known antiviral species and was administered as a rhizome
extract. A decoction of the bark of Uncaria tomentosa was used as
immunostimulant. Dr. Incháustegui used indistinctly Uncaria tomentosa
and Uncaria guianensis
According to Dr. Incháustegui, most of his
patients treated with this mixture resulted negative for AIDS virus after six
months of treatment, on average. However, until date Dr. Incháustegui has not
published any clinic results in any serious medical journal. In spite of that,
this mixture continues being used in Peru —and since the late 1990s in Eastern
Europe— to treat AIDS and herpes zoster.
Father Edmund Szeliga —a Polish Salesian
missionary living in Peru for 7 decades and a self-taught phytotherapist —
affirms have had several cases of AIDS cured using Uncaria tomentosa
among other plants (Rybiński and Warszewski, 2000). He states “…It means
that those patients with full symptoms of AIDS – not just those who were
seropositive – after the treatment the density of viruses in the blood was
lowered to such an extent that they were virtually impossible to detect. We do
not say that the viruses disappeared entirely. We are cautious. We only state
that their number fell to beneath vestigial amounts...”. He also asseverates
that this is a permanent state and his observations indicate that the number
of viruses does not increase again after a while. His observations have never
been published in any medical journal and he also admits that he does not use
control groups.
Scientists at the Instituto de Medicina
Tradicional (Institute of Traditional Medicina), Iquitos, Peru, obtained
very good results in retarding the growth of in vitro HIV viruses. This
encouraged the commencement of volunteer testing. The results were more than
just promising. After a few weeks of taking the Uncaria tomentosa
infusion, the patients’ level of the HTLV virus dropped so significantly that
it became hardly detectable. At the same time the number of CD4 lymphocytes
rose. This proves that the functioning of the organism’s immune system, which
had been disturbed by illness, is being restored.
Circulatory system
Several different phytochemicals found in the
water extract of Uncaria tomentosa have demonstrated different actions
in the blood and heart.
Some alkaloids contained in the extract have
demonstrated hypotensive and vasodilating properties. These alkaloids are
rhynchophylline, hirsutine, and mitraphylline.
Rhynchophylline also has shown to inhibit
platelet aggregation and thrombosis. This compound was tested for a few years
at the School of Chinese Traditional Medicine in Shanghai. The analyses
conducted there show that rhynchophylline has the ability to inhibit the
accumulation of platelets and may also prevent and reduce blood clots in blood
vessels and relax the blood vessels of endothelial cells, dilate peripheral
blood vessels, lower the heart rate, and lower blood cholesterol. Three sterols
—beta sitosterol (80%), stigmasterol, and campesterol
— have been identified and proven to be mild inhibitors of
cholesterol synthesis in vitro (Field et al., 1997).
This also means that could help to prevent
atherosclerosis, inhibiting the formation of the atherosclerotic plaque that
occurs during the progression of atherosclerosis.
Various chemicals in it are known to promote the
loss of water from the body, relax smooth muscles, and widen small blood
vessels in the hands and feet. All these effects may help to lower blood
pressure.
It has also been proposed that the water extract
of Uncaria tomentosa could help prevent strokes, diseases of the
circulatory system, and heart attacks (due to its lowering C-reactive protein
level activity).
Chronic and Occasional Asthma Prevention
In order to treat chronic and occasional asthma,
a three-step herbal treatment has been proposed with good results. In the
first step, a decoction of manayupa (Desmodium mollicum), a cleansing
herb, is administered to cleanse or detoxify the body. In the second step, a
decoction of two curative herbs, asmachilca (Eupatorium triplinerve),
and mullaca (Muehlenbeckia vulcanica) is administered; these herbs
diminish the hyperactivity and inflammation of the respiratory mucous membrane
and fluidize bronchial secretions. During the third step, a decoction of the
stem bark of Uncaria tomentosa is administered as a preventive herb.
Effectively,Uncaria tomentosa is known
for its immunostimulating action (increase the organism's defenses) which
contributes to prevent the asthmatic crisis. It has also anti-inflammatory
properties which counters the bronchial edema. A study on 100 bronchial asthma
patients treated with these medicinal plants was carried out at the Peruvian
Institute of Phytotherapeutic Research in Lima between 1988 and 1991.
Cleansing, curative, symptomatic and preventive plants were administered to 51
male and to 49 female patients with good results.
Antiviral
The water extract of Uncaria tomentosa
has also shown in vivo antiviral properties. The same glycosides that
have shown anti-inflammatory properties have also shown antiviral properties.
A mixture of an extract from the bark of
Uncaria tomentosa and the rhizome of Dracontium loretense K. Krause
“sacha jergón” has been proposed as a treatment against herpes zoster.
Uncaria tomentosa is also a promising
source of systemic broad-spectrum antivirals that may cause less damage to
host cells infected by chronic viruses than do pharmaceuticals.
Uncaria tomentosa also increases the
production of leukocytes, and particularly the lymphocytes T4, which fight
many viral diseases.
Antiviral activity of quinovic acid glycosides
from Uncaria tomentosa has also been analyzed (Aquino, Simone, and
Pizza, 1989). An inhibitory effect against vesicular stomatitis virus
was evident for all the nine compounds tested, although at relatively high
concentrations with respect to the toxic dose. In other words, the antiviral
activity was weak unless you approach the point where the herbal components
would kill the cells as well. The authors also showed that almost all
these quinovic acid glycosides were inactive against rhinovirus type IB
infection.
Digestive Tract
Traditionally, a water decoction of the bark and
root of Uncaria tomentosa has been used in several regions of South
America to treat stomach and intestinal affections, such as ulcers, dysentery,
gastritis, etc.
The extract of Uncaria tomentosa can also
be considered as a gastrointestinal decongestionant. It has the ability to
cleanse the entire intestinal tract. Its effectiveness has also been proven in
treating stomach and bowel disorders, such as Crohn's disease, leaky bowel
syndrome, ulcers, gastritis, diverticulitis, irritable bowel syndrome, and
other inflammatory conditions of the bowel, stomach, and intestines.
In an in vivo rat study, the water
extract of Uncaria tomentosa was shown to be effective against stomach
ulcers. Dr Brent Davis, a doctor who has been using Uncaria tomentosa
for years in clinical practice in the USA considers that this climbing plant
is an excellent medicine for many diseases, among other things, diseases of
the digestive system. This plant has a phenomenal predisposition towards
cleansing of the whole digestive tract, which is important because, as many
doctors claim, “… death begins with the intestines, in the colon, to be more
precise…”.
Dr. Davies also considers that in Western
countries we consume food of such composition and consistency that it hinders
excretion from the organism. “…With age and the organism growing flaccid,
mini-hernias form in the colon, where the substances that are normally
designed for excretion accumulate. When they get there they wedge and remain
too long, and systematically contaminate the circulation of blood instead of
leaving the organism. Uncaria tomentosa, however, prevents this - it
cleans all depressions throughout the whole intestine. Who knows if this is
not the most important, most blessed, of its workings?...”, he argues.
The depressions Dr. Davies refers to are called
diverticula. Diverticula form in elder people, especially in developed
countries, and is due to the diet scarce in fiber. These depressions, similar
to fingers of gloves, can be filled with fecal matter, which accumulates for a
long period of time and host many kinds of bacteria. These bacteria can infect
the human tissue of the intestines and cause an inflammation called
diverticulitis.
Apart from this, as has been found out,
Uncaria tomentosa is helpful in treatment of the Crohn’s disease, the
inflammation of the colon (colitis), and hemorrhoids, and also prevents
disturbances in the equilibrium of the intestinal flora. This plant is also
supposed to alleviate intestinal parasites and Candida (according to
the observations of many physicians, but other interventions at the same time
are needed for optimal effect).
Miscellaneous
In 2000, a research demonstrated that the water
extract of Uncaria tomentosa had antioxidant properties. In Argentina,
another study also concluded that the water extract of Uncaria tomentosa
is an effective antioxidant. The phytochemicals with antioxidant properties
found in the Uncaria tomentosa extract are catechins and procyanidins,
and also contribute to the anti-inflammatory properties.
Some companies are marketing a formulation made
from Uncaria tomentosa and Bixa orellana L. as a healing,
anti-inflammatory and diuretic agent. They claim that it is a product with a
singular effect over the genitourinary tract and that is specially recommended
in promoting prostate health and normal urinary function in men.
In a 2000 Swedish study, Sheng et al.
using an aqueous extract treated radiation-induced DNA damage in rats. Results
indicated significant repair of DNA breaks.
The oleanolic acid isolated from Uncaria
tomentosa has shown anti-allergy actions, but the amounts are so small as
to make their presence insignificant in relation to the herbal activity in
clinical practice. This substance also shows appreciable antistaphylococcal
activity (MIC 8 µg ml-1) against Staphylococcus aureus.
According to anecdotal information, Uncaria
tomentosa facilitates the expulsion of Entamoeba histolytica (a
type of detrimental Protozoa) from the body (especially when used in
conjunction with Methylsulfonylmethane (MSM)).
Uncaria tomentosa is also considered a
nutritional support for people with lupus erythematosus. However, there is one
case report of acute renal failure in an adult with systemic lupus
erythematosus who took Uncaria tomentosa. Some authorities even advise
people with systemic lupus erythematosus not to use Uncaria tomentosa.
In some cases, it is part of adjuvant
nutritional therapy for people with Chronic Fatigue Syndrome (CFS): numerous
people report relief of symptoms of CFS after using Uncaria tomentosa
for at least one month.
This plant is also part of adjuvant nutritional
therapy for people with diabetes mellitus.
According to the observations of many
physicians, it may alleviate bursitis. Some physicians are also promoting it
in order to treat depression.
Uncaria tomentosa also helps to minimize
the toxic effects of tobacco smoking. Effectively, this plant significantly
reduces the mutagenicity of substances present in the urine of tobacco smokers.
Some indigenous groups only use the water stored
in the stem to quench thirst, and as a restorative drink.
Finally, from the stems (not bark) of Uncaria
tomentosarattan-like furniture can be woven. In Iquitos, Peru, a demand
for this kind of furniture exists.
Phytochemicals:
ajmalicine
akuammigine
alkaloids (at least 17 different ones)
campesterol
catechin
chlorogenic acid
cinchonain
corynantheine
corynoxeine
daucosterol
epicatechin
flavonoids
formaosine-N-oxide
harman
hirsuteine
hirsutine
isomitraphylline
isopteropodine
isorhynchorphylline
loganic acid
lyaloside
mitraphylline
oleanolic acid
palmitoleic acid
pentacyclic oxindole alkaloids
procyanidins
pteropodine
quinovic acid glycosides
rhynchophylline
rutin
sitosterols
speciophylline
sterol fractions
stigmasterol
strictosidines
tannins
triterpenes
uncarine A-F
uncarine F-N-oxide
vaccenic
The first chemical analysis of Uncaria
tomentosa was published in 1974 by Hemingway and Phillipson. They found
tetracyclic and indole alkaloids. Montenegro de Matta et al. (1976)
reported for the first time the presence of pentacyclic alkaloids in the vine
bark of both Uncaria tomentosa and Uncaria guianensis
Indole alkaloids are widely found in a
considerable number of medicinal products from plants (Tyler, 1981).
Uncaria tomentosa also contains a number of oxindole alkaloids.
Isopteropodine-HCl, an oxindole alkaloid
isolated from the root, was shown to be the most potent of the tested
compounds, whereas pteropodine, isomitraphylline, and isorhynchorphylline had
weaker activity, and no immunomodulating activity was found in mitraphylline
or rhynchophylline (Labadie et al., 1993).
Total alkaloid content: from 0.7% to 1.6%, with
the overall average about 1.2%.
Pentacyclic oxindole alkaloids:
Pteropodine, Isopteropodine, Speciophylline, Uncarine F, Mitraphylline,
Isomitraphylline. Total content: 90%.
Tetracyclic oxindole alkaloids:
Rhynchophylline, Isorhynchophylline, Corynoxeine, Isocorynoxeine. Total
content: 10%.
Chemical Composition of the Leaves: iso
ajmalicine, Akuammigine, dihydro -Corynantheine, Corynoxeine, iso-Corynoxeine,
Hirsuteine, Hirsutine, Mitraphylline, iso Mitraphylline, Pteropodine,
Rhynchophylline, iso-Rhynchophylline, Speciophylline, Uncarine E, Uncarine F.
The inner bark of Uncaria tomentosa
contains up to 0.5% Pentacyclic Oxindole Alkaloids (POA). The roots and leaves
contain higher levels of Pentacyclic Oxindole Alkaloids than the stem bark.
6. DOSE AND CONTRAINDICATIONS
Caution: ‘Cat’s claw’ [
Uncaria tomentosa (Willd.) DC] should not be confused with a plant known
as ‘cat’s claw acacia’ (or Acacia gregii), a
tree-like shrub that grows in the United States and Mexico. ‘Cat’s claw
acacia’ contains chemicals (a cyanide derivative) that may be harmful if
ingested.
In Peru, there are also several other plant
species called ‘uña de gato’ (Caesalpinia sp.,
Macfadyena unguis-cati, Macfadyena uncata and other
species).. Be sure you are always getting Uncaria tomentosa and not
other plant species.
Dose: Traditionally, Uncaria tomentosa
is mainly administered as a decoction. The most common forms used today
are capsules and tablets. Fluid extracts (tinctures), powdersfrom the whole
dry inner bark, the root, and the leaves of the vine, crude extracts, and
various alcohol extracts from 1:1 to 8:1 are also available. There also exist
several proprietary extracts containing just some phytochemicals extracted
from the decoction of the bark. However, some authorities think that the best
alternative is the natural vine bark prepared in the same way Amazon tribes
are used to do (that is, as a concentrated decoction).
-
Traditionally, some Peruvian tribes boil 5 to 6 kilograms of the root of
Uncaria tomentosa in water until it is reduced to little more than 1 cup.
This decoction is then taken 1 cup daily during the period of menstruation for
three consecutive months, which supposedly causes sterility for three to four
years.
-
Other authorities report that typically, the indigenous people of Peru boil 20
- 30 grams of Uncaria tomentosa inner bark and/ or root in a liter of
water for 30 - 60 minutes to prepare a tea. (If the tea is shredded, 30
minutes is sufficient.) This is then consumed throughout the day for several
days to several months. This protocol can be used for the treatment of serious
conditions.
-
For general immune and health benefits, modern medicine usually recommend 500
mg to 1 g daily of Uncaria tomentosa powder in tablets or capsules.
-
Therapeutic dosages of Uncaria tomentosa can be as high as 10 g daily.
-
Generally, as a natural aid for arthritis, bowel, and digestive problems 3 g
to 5 g daily is recommended.
-
Dosages for a standard decoction for general health and maintenance is 1/2-1
cup of a decoction once daily and up to 1 cup three times daily in times of
special needs. Adding lemon juice or vinegar to the decoction when boiling
will help extract more alkaloids and less tannins from the bark. Use about 1/2
teaspoon of lemon juice or vinegar per cup of water.
-
In Peru, modern herbal medicine recommends a decoction of 20 g to 30 g of bark
drunk several times per day.
-
For rheumatoid arthritis, common extract doses in clinical trials have been 60
mg per day.
-
For osteoarthritis, common extract doses in clinical trials have been 100 mg
per day.
-
As a prophylactic anti-flu treatment it has been suggested one glass of a
decoction prepared from Uncaria tomentosa, twice a day, 30 minutes
before a meal or 2 capsules twice a day, 30 minutes before a meal. The
prophylactic treatment should be applied throughout the autumn-winter season
but for at least three months.
-
The recommended dose for a commercial extract from the roots of Uncaria
tomentosa with a minimum of 1.3% pentacyclic oxindole alkaloids free of
tetracyclic oxindole alkaloids is one 20 mg capsule three times per day for
the first ten days and then one capsule thereafter.
-
The suggested dosage for a low-molecular-weight fraction hot-water commercial
extract from the whole plant containing eight-percent carboxyl alkyl esters is
100 mg three times per day.
-
The dosage for C-Med-100, a patented extract of Uncaria tomentosa bark
standardized to eight-percent carboxyl-alkyl-esters, is 300 mg daily.
-
To make a tea from the dry bark, Mejia et al. (1995) recommends 100
grams per liter of water, slowly boiled for up to an hour or longer.
-
For tinctures, the general dosage is 1 mL 1-3 times daily.
-
For dry extracts, the general dosage is 500 mg to 2 000 mg mixed in water 1-3
times daily.
-
Dr Philip N. Steinberg, American scientist conducting research into the
applications of Uncaria tomentosa since 1993, recommends
therapeutically from 3 to 6 grams of Uncaria tomentosa per day, at best
divided into three doses. When used for prevention, the dosage should be three
times smaller, making use of the antioxidant activities of the organism and
its increasing adaptive capabilities. In advanced pathological states, he even
uses up to 20 grams per day in one dose for a few consecutive weeks.
-
As an anti-tumor prophylaxis, a two-stage treatment has been proposed. The
first is a six-week purifying stage with manayupa, flor de arena and
hercampuri. The second is a 3-month immunostimulant stage with Uncaria
tomentosa (1 glass of an infussion or 1 capsule twice a day, 30 minutes
after meals), tahuari (1 glass of a decoction, twice a day, one hour before or
two hours after a meal), sangre de grado (5 drops dissolved in water or fruit
juice, once a day, after a meal) and sacha jergón (1 capsule, 3 times a day,
30 minutes before a meal) simultaneously. The whole treatment can be repeated
after 6 months.
-
A two-stage treatment as a rejuvenating and revitalizing, recommended in hair
loss, has been proposed. The first is a six-week purifying stage with
manayupa, flor de arena and hercampuri. The second is a 3-month stage with
Uncaria tomentosa (1 glass of an infusion or one capsule twice a day, 30
minutes before a meal), chuchuhuasi (one glass of a decoction three times a
day, one hour before or two hours after a meal), maca (one capsule three times
a day during meals), zarzaparrilla (1 capsule three times a day, 30 minutes
before a meal). After a thirty-day break, the second stage of the treatment
can be repeated.
-
Against persistent dermatomycosis, acne and chronic bacterial and viral
infections, a two-stage treatment is recommended. During the first stage, use
manayupa for two weeks. For the second stage, take for three months
canchalagua (capsule three times a day, 30 minutes before a meal) and
Uncaria tomentosa (1 glass of an infusion or one capsule three times a
day, 30 minutes before a meal). The whole treatment can be repeated after a
three-month break.
-
A treatment recommended in frequent colds, chronic sinusitis, relapsing
pneumonia, chronic bronchitis, relapsing tonsillitis (phlegmonous angina),
chronic laryngitis, pharyngitis, bronchial asthma and allergies: first, a
purifying stage with manayupa for three weeks. Then, for three months,
Uncaria tomentosa (1 glass of an infusion or one capsule three times a
day, 30 minutes before a meal) and wira-wira, muña-muña or asmachilca (one
glass of a warm decoction of one of the above herbs, once a day before sleep).
-
For Parkinson’s syndrome, Parkinson’s disease, Alzheimer’s disease and
multiple sclerosis: first, a purifying stage with manayupa, flor de arena and
hercampuri. Then, Uncaria tomentosa (1 glass of an infusion or one
capsule three times a day, 30 minutes before a meal), chuchuhuasi (one glass
of a decoction three times a day, one hour before or two hours after a meal),
maca (one capsule three times a day during meals). Treatment of neurological
diseases is long-term, and thus stage two has no time limits. Chuchuhuasi and
maca can be taken for indefinite period, while Uncaria tomentosa
for up to 6 months. Uncaria tomentosa can be administered again after a
three-month break.
-
For neurosis, migraine, headaches and as supplementary therapy in the
treatment of epilepsy, follow a purifying treatment with manayupa, flor de
arena and hercampuri. Then, for three months, Uncaria tomentosa (one
capsule three times a day, 30 minutes before a meal), flor de arena (half a
glass of an infusion three times a day, an hour before or two hours after a
meal) and marco (1 glass of a decoction three times a day, 30 minutes before a
meal). The second stage can be repeated after a thirty-day break.
-
A Treatment recommended in flatulence, hyperacidity, intestinal infections,
diarrhea, chronic gastroenteritis, chronic gastritis, duodenal and gastric
ulcers, Crohn’s disease and ulcerative colitis: first stage, purification with
manayupa, flor de arena and hercampuri. Secondly, for three months, Uncaria
tomentosa (1 glass of an infusion, one capsule three times a day, 30
minutes before a meal), sangre de grado (5 drops dissolved in water three
times a day, during or after a meal) and ubos (1 glass of a decoction three
times a day, 30 minutes before meals).
-
For habitual constipation, begin with purification with manayupa, flor de
arena and hercampuri. Then, for three months, take Uncaria tomentosa (1
capsule three times a day, 30 minutes before a meal), and copaiba oil (5 drops
mixed with water or fruit juice three times a day, 30 minutes before a meal).
-
For chronic viral hepatitis B and C, cirrhosis and fatty degeneration of the
liver, purify your liver for two weeks with manayupa (one glass of a decoction
three times a day, one hour before or two hours after a meal). Then, for three
months, take Uncaria tomentosa (1 glass of an infusion or one capsule
three times a day, 30 minutes before a meal), hercampuri (one capsule three
times a day, one hour before or two hours after a meal), chancapiedra (2
capsules three times a day, one hour before or two hours after a meal), sangre
de grado (5 drops dissolved in water, three times a day, during or after a
meal).
-
For chronic pyelonephritis, urocystitis and infections of the urinary system,
begin with a purification with manayupa, flor de arena and hercampuri. Then,
take Uncaria tomentosa (1 glass of an infusion or one capsule three
times a day, 30 minutes before a meal), flor de arena (one glass of an
infusion three times a day, one hour before or two hours after a meal),
achiote (2 capsules three times a day, immediately after a meal), and
asmachilca (one glass of a decoction once a day immediately before sleep,
until symptoms disappear but no shorter than one month and no longer than 3
months.
-
For prostatitis and prostatic hypertrophy, a two-week purification stage with
flor de arena (1 glass of an infusion three times a day, one hour before or
two hours after a meal), and hercampuri (1 capsule three times a day, one hour
before or two hours after a meal). Then, Uncaria tomentosa (10 drops of
a liquid extract mixed with water or fruit juice three times a day, 30 minutes
before a meal), and achiote (2 capsules three times a day, immediately after a
meal), jergon sacha (2 capsules three times a day, 30 minutes before a meal).
On completion of the second stage one should make a thirty-day break. Then the
whole of the second stage can be repeated.
-
As a general anti-tumor treatment, recommended in malignant diseases, leukemia
and multiple myeloma, start with a purification stage with manayupa, flor de
arena and hercampuri. Then, as a second stage, for three months, Uncaria
tomentosa (20 drops of a liquid extract mixed with water or fruit juice
three times a day, 30 minutes before a meal), tahuari (1 glass of a decoction
three times a day, one hour before or two hours after a meal), sangre de grado
(5 drops dissolved in water, three times a day, during or after a meal),
asmachilca (one glass of a decoction three times a day immediately before
sleep). On completion of stage two, continue with stage three for three
months: Uncaria tomentosa, tahuari and sangre de grado like in stage
two, and simultaneously ubos (1 glass of a decoction three times a day, 30
minutes before a meal). On completion of the third stage, i.e. after
six months, one should stop taking Uncaria tomentosa for three months.
Other preparations of the third stage (i.e. tahuari, sangre de drago
and ubos) can still be applied in doses described above.
-
For breast tumors, initiate with a purification stage with manayupa, flor de
arena, and hercampuri. Then, take for three months Uncaria tomentosa
(20 drops of a liquid extract mixed with water or fruit juice three times a
day, 30 minutes before a meal), jergon sacha (2 capsules three times a day, 30
minutes before a meal), sangre de grado (5 drops, dissolved in water or fruit
juice, three times a day, during or after a meal)
-
For tumors of the alimentary tract, begin with the purification treatment with
manayupa, flor de arena, and hercampuri. Then, for one month, follow with
Uncaria tomentosa (20 drops of a liquid extract mixed with water or fruit
juice three times a day, 30 minutes before a meal), tahuari (1 glass of a
decoction three times a day, one hour before or two hours after a meal),
sangre de grado (5 drops, dissolved in water, three times a day during or
after a meal), copaiba oil (5 drops mixed with water or fruit juice three
times a day, half an hour before a meal), and asmachilca (one glass of a
decoction once a day immediately before sleep). After that, continue with
Uncaria tomentosa, tahuari and sangre de grado, as in stage two, and
simultaneously, zarzaparrilla and (2 capsules three times a day, 30 minutes
before a meal), asmachilca (one glass of a decoction once a day immediately
before sleep). Finally, in stage four (1 month), take Uncaria tomentosa
, tahuari and sangre de grado, as in stage two, and simultaneously,
chancapiedra (1 capsule three times a day, an hour before or two hours after a
meal), and asmachilca (one glass of a decoction once a day immediately before
sleep). On completion of the fourth stage one should make a thirty-day break.
-
For prostate tumors, begin with a purification treatment with manayupa (half a
glass of a decoction three times a day, one hour before or two hours after a
meal), flor de arena (half a glass of an infusion three times a day, one hour
before or two hours after a meal), and hercampuri (one capsule three times a
day, one hour before or two hours after a meal). Then, for three months, stage
two: Uncaria tomentosa (20 drops of a liquid extract mixed with water
or fruit juice three times a day, 30 minutes before a meal), achiote (2
capsules three times a day immediately after a meal), jergón sacha (1 capsule
three times a day 30 minutes before a meal), sangre de grado (5 drops
dissolved in water or mixed with fruit juice, three times a day, during or
after a meal) and asmachilca (one glass of a decoction once a day immediately
before sleep). Then, make a thirty-day break, after which the whole second
stage of the treatment can be repeated.
-
For brain tumors, start for one week with a purification treatment with
manayupa (half a glass of a decoction three times a day, one hour before or
two hours after a meal), flor de arena (half a glass of an infusion three
times a day, one hour before or two hours after a meal), and hercampuri (one
capsule three times a day, one hour before or two hours after a meal). Then,
Uncaria tomentosa (20 drops of a liquid extract mixed with water or fruit
juice three times a day, 30 minutes before a meal), tahuari (1 glass of a
decoction three times a day, one hour before or two hours after a meal),
sangre de grado (5 drops dissolved in water, three times a day during or after
a meal), zarzaparrilla (2 capsules three times a day, 30 minutes before a
meal) and asmachilca (one glass of a decoction once a day immediately before
sleep). On completion of the last stage one should make a thirty-day break.
-
For disseminated and advanced tumors, begin with 1 week of purification with
manayupa (half a glass of a decoction three times a day, one hour before or
two hours after a meal), flor de arena (half a glass of an infusion three
times a day, one hour before or two hours after a meal), and hercampuri (one
capsule three times a day, one hour before or two hours after a meal). Then,
as stage two, take for a month Uncaria tomentosa (20 drops of a liquid
extract mixed with water or fruit juice three times a day, 30 minutes before a
meal), tahuari (1 glass of a decoction three times a day, one hour before or
two hours after a meal), sangre de grado (5 drops dissolved in water three
times a day during or after a meal), and asmachilca (one glass of a decoction
once a day immediately before sleep). After that, continue with stage three (1
month): Uncaria tomentosa, tahuari and sangre de grado like in stage
two, and simultaneously take asmachilca (one glass of a decoction once a day
immediately before sleep), copaiba oil (5 drops mixed with water or fruit
juice three times a day, half an hour before a meal). On completion of stage
three start with stage four: zarzaparrilla (2 capsules three times a day 30
minutes before a meal). Each time wash them down with 1 glass of a decoction
prepared from: ubos (1 spoonful) muña-muña (1 spoonful), Uncaria
tomentosa (1 spoonful of liquid extract). Boil the three ingredients
together for 20 minutes in 1 litre of water. Drink 1 glass of the decoction
three times a day half an hour before a meal.
Contraindications:
-
Due to its documented immunostimulant properties, extracts of Uncaria
tomentosa are not recommended before or after any organ or bone marrow
transplant or skin graft.
-
Ethnomedically, a highly concentrated extract of Uncaria tomentosa has
been documented with antifertility properties. Although this effect has not
been proven to be sufficient to be used as a contraceptive, women seeking to
get pregnant should avoid using it until more information is available.
-
Large dosages of Uncaria tomentosa (3-4 gram dosages) have been
reported to cause some abdominal pain or gastrointestinal problems including
diarrhea (due to the tannin content of the vine bark). The diarrhea or loose
stools tend to be mild and go away with continued use. Discontinue use or
reduce dosage if diarrhea persists longer than 3-4 days.
-
Until more information is available, pregnant and breast feeding women and
women attempting pregnancy should avoid taking this product. Some authorities
believe that Uncaria tomentosa may increase the probability of
miscarriage. The same is advisable for children under 3 years old.
-
Although Murray (2000) states that Uncaria tomentosa may be helpful in
rheumatoid arthritis, long-term use should be avoided in patients with
autoimmune disorders until further information is available.
-
Some authorities consider that Uncaria tomentosamust not be given to
people who take insulin and vaccines, people suffering from hemophilia, and
also patients who are subject to some hormone therapies. Do not take
Uncaria tomentosa within three days before and three days after
vaccination against contagious diseases.
Drug Interactions:
-
As all alkalizing agents (Alugastrin, Gel, Aluminii Phosphorici, Manti,
Renigast, Omeprasol, Losec etc.) inhibit the absorption of active medicinal
substances contained in Uncaria tomentosa preparations, patients who
use the above agents should increase doses of Uncaria tomentosa twofold.
-
The extract of Uncaria tomentosa could interact with medications
intended to suppress the immune system, such as cyclosporin or other
medications prescribed following an organ transplant.
-
The extract of Uncaria tomentosa could interact with blood thinning
drugs. Some chemicals in Uncaria tomentosa have been reported with the
ability to reduce platelet aggregation and, hence, thin the blood. If you are
taking any blood thinning drug, get the advise of your doctor.
-
Avoid taking antacids at the same time as Uncaria tomentosa capsules or
tablets. Uncaria tomentosa requires sufficient stomach acid to help
break down the tannins and alkaloids during digestion and to aid in absorption.
-
Avoid taking high tannin (dark colored) liquid extracts directly by mouth and
dilute first in water or acidic juice.
-
Since the rhynchophylline alkaloids contained in Uncaria tomentosa have
antihypertensive effects, it may potentiate the action of antihypertensive
drugs and their concurrent use should be avoided.
-
Because it may be broken down by certain enzymes in the liver, cat’s claw may
possibly interfere with the use of prescription drugs that are processed by
the same enzymes. Some of these drugs are:
· Allergy drugs like fexofenadine (Allegra)
· Antifungal drugs like itraconazole (Sporanox)
and ketoconazole (Nizoral)
· Cancer drugs like etoposide, paclitaxel,
vinblastine, or vincristine
· Drugs for high cholesterol like lovastatin
· Oral contraceptives
Precautions:
-
Stop using extracts of Uncaria tomentosa one week to ten days prior to
any major surgical procedure. Some chemicals in the extract can reduce
platelet aggregation and thin the blood.
-
Although it has not been proven, it is advisable to stop taking Uncaria
tomentosa after an organ transplant.
-
Uncaria tomentosais not intended to replace any kind of medical treatment
(anticancerous, antiviral, etc.). Any person with a serious health problem
should seek treatment from a health care professional. Those already
undergoing physician-prescribed therapy should neither stop taking, nor reduce
the dosage of such treatment without their physician’s directions.
-
Any persons currently taking prescription medication should consult their
physician before taking Uncaria tomentosa.
-
Due to the bitterness of Uncaria tomentosa, mild nausea may occur upon
ingestion of crude extracts or teas.
-
In one study, a case of diarrhea upon the administration of a concentrated
extract of Uncaria tomentosa was reported. However, no other
gastrointestinal events have been associated with this plant.
-
Some authorities recommend not to use Uncaria tomentosaduring
chemotherapy and radiotherapy. It may be administered three days after the end
of chemo- and radiotherapy but should be terminated three days before another
chemo- and radiotherapy session.
-
Do not take Uncaria tomentosa -in the case of blood transfusion or when
blood-derived preparations are taken. It may be administered three weeks after
transfusion but should be terminated one week before planned transfusion.
Toxicity:
-
Uncaria tomentosa is generally thought of as safe, with an LD50
of the aqueous extract in mice greater than 16 g/kg. In recommended dosages,
Uncaria tomentosa is considered non-toxic.
-
In a study (Sheng, 2001), the LD50 of a single dose of C-MED-100, a novel
water extract of Uncaria tomentosa, was determined to be greater than 8
mg/kg.
-
Santa Maria et al. (1997) also determined Uncaria tomentosa to
be non-toxic by in vitro bioassays of Chinese hamster ovary cells and
cells of the bacterium Photobacterium phosphorem.
7. LITERATURE REVISED
Aguilar JL, et al. "Anti-inflammatory activity
of two different extracts of Uncaria tomentosa (Rubiaceae)." J.
Ethnopharmacol. 2002; 81(2): 271-76.
Aquino R, De Feo V, De Simone F, et al. Plant
metabolites. New compounds and anti-inflammatory activity of Uncaria
tomentosa. J Nat Prod 1991;54:453-459.
Aquino R., et al. "New polyhydroxylated
triterpenes from Uncaria tomentosa." Journal of Natural Products 1990: 559-64.
Aquino, R., et al. "Plant metabolites. New
compounds and anti-inflammatory activity of Uncaria tomentosa." Journal of
Natural Products 1991; 54: 453-59.
Aquino, R., et al. "Plant metabolites. Structure
and in vitro antiviral activity of quinovic acid glycosides from Uncaria
tomentosa and Guettarda platypoda." J. Nat. Prod. 1989; 4(52): 679-85.
Beckstrom-Sternberg S, Duke J, Wain K. Chemicals
in: Uncaria tomentosa DC (Pedaliaceae). 1994: The Ethnobotany Database,
Agricultural Research Service.
Cabieses, Fernando. The Saga of the Cat's Claw.
Lima: Via Lactea Editores, 1994.
Castillo, G., et al. "Pharmaceutical
compositions containing Uncaria tomentosa extract for treating Alzheimer's
disease and other amyloidoses." Patent-Pct. Int. Paol. 1998; 00 33,659 : 67pp.
Center for Alternative Medicine in Cancer. Cat's
claw. CAMC 1999: http:www.sph.uth.tmc.edu/utcam/therapies/cat/htm.
Cerri, R., et al. "New quinovic acid glycosides
from Uncaria tomentosa." Journal of Natural Products 1988; 51: 257-61.
Chan-Xun, C., et al. "Inhibitory effect of
rhynchophylline on platelet aggregation and thrombosis." Acta
Pharmacologica Sinica 1992; 13(2): 126-30.
de Simone, F., et al. "New quinovic acid
glycosides from Uncaria tomentosa." Journal of Natural Products 1988; 51(2):
257-61.
Desmarchelier, C., et al. "Evaluation of the in
vitro antioxidant activity in extracts of Uncaria tomentosa (Willd.) DC."
Phytother. Res. 1997; 11(3): 254-256.
Dharmananda S. Uncaria tomentosa (cat's claw):
Institute for Traditional Medicine.1994.
Dixon RA. Natural products and plant disease
resistance. Nature 2001; 411: 843-847.
Falkiewicz B, Lukasiak J. Vilcacora, Uncaria
tomentosa (Willdenow ex Roemer and Schultes) DC. (Rubiaceae). Andean Medicine
Center, Ltd. 2000.
Fazzi, Marco A. Costa. "Evaluation de l'Uncaria
tomentosa (Uña de gato) en lan prevencion de ulceras gastricas de stress
producidas experimentalmente en rats." Dissertation of the faculty of
medicine, University Peruana Cayetano Heredia, Lima, Peru, 1989.
Field F, Born E, Mathur S. Effect of micellar
beta-sitosterol on cholesterol metabolism in CaCo-2 cells. J. Lipid Res. 1997;
38:348-60.
Flores V. Evaluacion de extractos liofilizados
de plantas medicinales como inmunoestimulantes de la actividad fagocitaria.
Biodiversidad y Salud: Revista Amazonica de Investigacion Cientifica en
Plantas Medicinales de EsSalud 1999; 1:20-22.
Ganzera M, Muhammad I, Khan R, et al. Improved
method for the determination of oxindole alkaloids in Uncaria tomentosa by
high performance liquid chromatography. Planta Med 2001;67:447-450.
Gotuzzo, E., et al. "En marcha seria
investigacion: Uña de gato y pacientes con el VIH." De Ciencia y Tecnologia
1993; 34.
Hemingway, S. R. and J. D. Phillipson.
"Alkaloids from South American species of Uncaria (Rubiaceae)." Journal of
Pharmacy and Pharmacology 1974 suppl.; 26: 113p.
Inchaustegui and Gonzales, R. "Estudio
preliminar sobre. CAS y SIDA." Utilizando Plantas Medicinales, Anos 1989-1994,
Hospital IPSS, Iquitos, Peru. Iquitos, Peru: Hospital del Instituto Peruano de
Seguridad Social Iquitos Comite ETS-SIDA, February 1993, 24 pp.
Jin, R. M., et al. "Effect of rhynchophylline on
platelet aggregation and experimental thrombosis." Acta Pharmacologica
Sinica 1991; 25: 246-49.
Keplinger K, Laus G, Wurm M, et al. Uncaria
tomentosa (Willd.) DC. ethnomedicinal use and new pharmacological,
toxicological and botanical results. J Ethnopharmacol 1999;64:23-34.
Keplinger, H., et al. "Oxindole alkaloids having
properties stimulating the immunologic system and preparation containing
same." United States patent 5,302,611; April 12, 1994.
Keplinger, H., et al. "Oxindole alkaloids having
properties stimulating the immunologic system and preparation containing the
same." United States patent 4,940,725; July 10, 1990.
Keplinger, H., et al. "Oxindole alkaloids having
properties stimulating the immunologic system and preparation containing the
same." United States Patent 4,844,901; July 4, 1989.
Keplinger, H., et al. "Process for the
production of specific isomer mixtures from oxindole alkaloids." United States
Patent 5,723,625; March 3, 1998.
Keplinger, U. M. "Einfluss von Krallendorn
extract auf Retrovirale Infektioned," Zurcher AIDS Kongress. Zurich,
Switzerland, October 16 and 17, 1992, program and abstracts.
Keplinger, U. M., "Therapy of HIV-infected
individuals in the pathological categories CDC Al and CDC B2 with a
preparation containing IMM-207," IV. Osterreichicher AIDS-Kongress, Vienna,
Austria, September 17 and 18, 1993, abstracts: 45.
Kitajami M, Hashimoto K, Yokoya M, et al. Two
new 19-hydroxyursolic acid-type triterpenes from Peruvian 'uña de gato'
(Uncaria tomentosa). Tetrahedron 2000;56:547-552.
Krallendorn, R., "Uncaria tomentosa (Willd.) DC
Root Extract. Information for Physicians, and Dispensing Chemists," 3d rev.
ed. Volders, Austria: Immodal. Pharmaka. GmbH., September 1995, 20 pages.
Kreutzkamp, B. "Niedermolekulare Inhalstoffe mit
Immunstimulierenden Eigenschaften aus Uncaria tomentosa, Okoubaka aubrevillei
und anderen Drogen." Dissertation of the faculty of chemistry and pharmacy of
Ludwig Maximilians University, Munich, May 1984.
Labadie R. Immunomodulatory compounds. In:
Colegate SM, ed Bioactive Natural Products: Detection, Isolation, and
Structural Determination. Boca Raton, FL: CRC Press: 1993.
Lamm, S., et al, "Persistent response to
pneumococcal vaccine in individuals supplemented with a novel water soluble
extract of Uncaria tomentosa, C-med-100." Phytomedicine. 2001; 8(4): 267-74.
Laus G, Brossner D, Keplinger K. Alkaloids of
Peruvian Uncaria tomentosa. Phytochemistry 1997;45:855-860.
Laus, G., et al. "Separation of sterioisomeric
oxindole alkaloids from Uncaria tomentosa by high performance liquid
chromatography." Journal of Chromatography 1994; 662: 243-49.
Lavault, M., et al. "Alcaloides de l'Uncaria
guianensis." Planta Medica 1983; 47: 244-45.
Lemaire I, et al. "Stimulation of interleukin-1
and -6 production in alveolar macrophages by the neotropical liana, Uncaria
tomentosa (uña de gato)." J. Ethnopharmacol. 1999; 64(2): 109-15.
Lemarie K, Assinewe V, Cano P, et al.
Stimulation of interleukin-1 and -6 production in alveolar macrophages by the
neotropical liana, Uncaria tomentosa (Uña de Gato). J Ethnopharmacol
2000;64:109-115.
Marina, M. D., "Evaluacion de la actividal
immunoestimulante de Uncaria tomentosa (Willd.) DC. Uña de gato en ratones
albinos." Biodiversidad Salud 1998; 1(1): 16-19.
Mejia K, Rengifo E. Plantas Medicinales de Uso
Popular en la Amazonia Peruana. Lima, Peru: AECI; 1995.
Mestanza D. Evaluacion de la actividad
inmunoestimulante de Uncaria tomentosa (Willd.) DC. uña de gato en ratones
albinos. Bioversidad y Salud 1999; 1:16-19.
Mohamed, A.F., et al. " Effects of Uncaria
tomentosa total alkaloid and its components on experimental amnesia in mice:
elucidation using the passive avoidance test." J. Pharm. Pharmacol. 2001;
52(12): 1553-61.
Montenegro De Matta, S., et al. "Alkaloids and
procyanidins of an Uncaria sp. from Peru." Il. Farmaco. Ed. Sc. 1976; 31:
527-35.
Muhammad I, Dunbar D, Khan R, et al.
Investigation on uña de gato I. 7-deoxyloganic acid and 15N NMR spectroscopic
studies on pentacyclic oxindole alkaloids from Uncaria tomentosa.
Phytochemistry 2001;57(5):781-785.
Mur, E., et al. "Randomized double blind trial
of an extract from the pentacyclic alkaloid-chemotype of Uncaria tomentosa for
the treatment of rheumatoid arthritis. J. Rheumatol. 2002 Apr; 29(4): 678-81.
Murray M. Saventero the powerful herb.
2000.
Ozaki, Y., et al. "Pharmacological studies on
Uncaria and Amsonia alkaloids." Japanese Journal of Pharmacology (suppl.)
1980; 30: 137pp.
Peluso, G., et al. "Effetto antiproliferativo su
cellule tumorali di estrattie metaboliti da Uncaria tomentosa. Studi in vitro
sulla loro azione DNA polimerasi." 11 Congreso Italo-Peruano de Etnomedicina
Andina, Lima, Peru, October 27-30, 1993, 21-2.
Pero RW. Method of preparation and composition
of a water soluble extract of the plant species Uncaria. HerbalGram
2000;49:30.
Recio, M. C., et al. "Structural requirements
for the anti-inflammatory activity of natural triterpenoids." Planta
Medica 1995; 61(2): 182-85.
Reinhart K. Uncaria tomentosa (Willd.) DC: cat's
claw, uña de gato, or Saventaro. J Altern Complement Med 1999;5:143-151.
Riva, L., et al. "The antiproliferative effects
of Uncaria tomentosa extracts and fractions on the growth of breast cancer
cell line." Anticancer Res. 2001; 21(4A): 2457-61.
Rizzi R, Re F, Bianchi A, et al. Mutagenic and
antimutagentic activities of Uncaria tomentosa and its extracts. J
Ethnopharmacol 1993;38:63-77.
Rizzi, R., et al. "Bacterial cytotoxicity,
mutagenicity and antimutagenicity of Uncaria tomentosa and its extracts.
Antimutagenic activity of Uncaria tomentosa in humans." Premiere Colloque
Européan d'Ethnopharmacologie, Metz, France, March 22-24, 1990.
Rybiński, Grzegorz y Roman Warszewski (2000).
“Vilcacora – the Miracle Cancer Cure”. Editorial Tower Press.
Gdańsk, Polonia.
Salazar, E. L., et al. "Depletion of specific
binding sites for estrogen receptor by Uncaria tomentosa." Proc. West.
Pharmacol. Soc. 1998; 41(1): 123-124.
Sandoval M, Charbonnet R, Okahama N, et al.
Cat's claw inhibits TNFalpha production and scavenges free radicals: role in
cytoprotection. Free Radical Biol Med 2000;29:71-78.
Sandoval M, et al., "Anti-inflammatory and
antioxidant activities of cat's claw (Uncaria tomentosa and Uncaria
guianensis) are independent of their alkaloid content." Phytomedicine 2002;
9(4): 325-37.
Sandoval, M., et al. "Cat's claw inhibits
TNFalpha production and scavenges free radicals: role in cytoprotection." Free
Radic. Biol. Med. 2000; 29(1): 71-8.
Sandoval-Chacon M, Thompson J, Zhang X, et al.
Antiinflammatory actions of cat's claw: the role of NF-kappaB. Aliment
Phamacol Ther 1998;12(12):1279-1289.
Santa Maria A, Lopez A, Diaz M, et al.
Evaluation of the toxicity of Uncaria tomentosa by bioassays in vitro. J
Ethnopharmacol 1997;57:183-187.
Sentore A, Cataldo A, Iaccarino F, et al.
Phytochemical and biological research on Uncaria tomentosa L. Boll Soc Ital
Biol Sper 1989;65:517-520.
Sheng Y, Bryngelsson C, Pero R. Enhanced DNA
repair, immune function and reduced toxicity of C-MED-100, a novel aqueous
extract from Uncaria tomentosa. J Ethnopharmacol 2000;69:115-126.
Sheng Y, et al., "DNA repair enhancement of
aqueous extracts of Uncaria tomentosa in a human volunteer study."
Phytomedicine 2001; 8(4): 275-82.
Sheng Y, et al., "Enhanced DNA repair, immune
function and reduced toxicity of C-MED-100, a novel aqueous extract from
Uncaria tomentosa." J. Ethnopharmacol. 2000; 69(2): 115-26.
Sheng Y, et al., "Treatment of
chemotherapy-induced leukopenia in a rat model with aqueous extract from
Uncaria tomentosa." Phytomedicine 2000; 7(2): 137-43.
Sheng Y., et al. "Induction of apoptosis and
inhibition of proliferation in human tumor cells treated with extracts of
Uncaria tomentosa." Anticancer Res. 1998; 18(5A): 3363-68.
Stuppner H, Strum S, Konwalinka G. Capillary
electrophoretic analysis of oxindole alkaloids from Uncaria tomentosa. J
Chromatogr 1992;609:375-380.
Stuppner, H., et al. "A differential sensitivity
of oxindole alkaloids to normal and leukemic cell lines." Planta Medica
(1993 suppl.); 59: A583.
Stuppner, H., et al. "HPLC analysis of the main
oxindole alkaloids from Uncaria tomentosa." Chromatographia 1992; 34(11/12):
597-600.
Syrimis A. Uncaria tomentosa: a review. British
J Phytotherapy 1998;5:29-31.
Tyler V, Brady L, Robbers J.Pharmocognosy.
Philadelphia: Lea & Febiger; 1981.
Wagner H, Kreutzkamp B, Jurcic K. The alkaloids
of Uncaria tomentosa and their phagocytosis-stimulating action. Planta Med
1985;54:19-23.
Wagner, H., et al. "Die Alkaloide von Uncaria
tomentosa und ihre Phagozytose-steigernde Wirkung." Planta Medica 1985; 51:
419-23.
Warszewski, Roman (1999). “Vilcacora Is A Gift
From God”. Editorial Tower Press. Gdańsk, Polonia.
Williams, James E. Review of Antiviral and
Immunomodulating Properties of Plants of the Peruvian Rainforest with a
Particular Emphasis on Uña de Gato and Sangre de Grado. Altern Med Rev
2001 Dec.; 6(6):567-579.
Wurm M, Kacani L, Laus G, et al. Pentacyclic
oxindole alkaloids from Uncaria tomentosa induce human endothelial cells to
release a lymphocyte-proliferation-regulating factor. Planta Med 1998;
64:701-704.
Yano, S., et al. "Ca2, channel-blocking effects
of hirsutine, an indole alkaloid from Uncaria genus, in the isolated rat
aorta." Planta Medica 1991; 57: 403-5.
Yasukawa, K., et al. "Effect of chemical
constituents from plants on 12-O-tetradecanoylphorbol-13-acetate-induced
inflammation in mice." Chemical and Pharmaceutical Bulletin 1989; 37: 1071-73.
Yepez, A. M., et al. "Quinovic acid glycosides
from Uncaria guianensis." Phytochemisty 1991; 30: 1635-37.